Cargando…

MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer

SIMPLE SUMMARY: Despite significant advances in treatment, breast cancer continues to be prevalent around the world. Metastasis associated in colon cancer 1 (MACC1) has been shown to be involved in the progression of more than 20 different types of cancer, including breast cancer, and performs speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Mengmeng, Jiao, Yunjuan, Yang, Bowen, Ye, Mengchen, Di, Wenyu, Su, Wei, Zhong, Jiateng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045309/
https://www.ncbi.nlm.nih.gov/pubmed/36979146
http://dx.doi.org/10.3390/biology12030455
_version_ 1784913571206922240
author Lv, Mengmeng
Jiao, Yunjuan
Yang, Bowen
Ye, Mengchen
Di, Wenyu
Su, Wei
Zhong, Jiateng
author_facet Lv, Mengmeng
Jiao, Yunjuan
Yang, Bowen
Ye, Mengchen
Di, Wenyu
Su, Wei
Zhong, Jiateng
author_sort Lv, Mengmeng
collection PubMed
description SIMPLE SUMMARY: Despite significant advances in treatment, breast cancer continues to be prevalent around the world. Metastasis associated in colon cancer 1 (MACC1) has been shown to be involved in the progression of more than 20 different types of cancer, including breast cancer, and performs specific functions in different cancers. MACC1’s biological role, molecular mechanism, and pathway are important for understanding cancer progression. MACC1 is highly expressed in breast cancer and has been linked to metastasis, staging, and a poor prognosis. This review article attempts to elucidate the prognostic value of MACC1 expression in breast cancer, its role in immune and anti-radiation therapy, and the network regulatory mechanisms involved, and discusses the application of MACC1 in the treatment and prevention of breast cancer. It is hoped that the use of MACC1 as a biomarker in breast cancer surveillance and clinical guidance can be promoted. ABSTRACT: Metastasis associated in colon cancer 1 (MACC1) is an oncogene first identified in colon cancer. MACC1 has been identified in more than 20 different types of solid cancers. It is a key prognostic biomarker in clinical practice and is involved in recurrence, metastasis, and survival in many types of human cancers. MACC1 is significantly associated with the primary tumor, lymph node metastasis, distant metastasis classification, and clinical staging in patients with breast cancer (BC), and MACC1 overexpression is associated with reduced recurrence-free survival (RFS) and worse overall survival (OS) in patients. In addition, MACC1 is involved in BC progression in multiple ways. MACC1 promotes the immune escape of BC cells by affecting the infiltration of immune cells in the tumor microenvironment. Since the FGD5AS1/miR-497/MACC1 axis inhibits the apoptotic pathway in radiation-resistant BC tissues and cell lines, the MACC1 gene may play an important role in BC resistance to radiation. Since MACC1 is involved in numerous biological processes inside and outside BC cells, it is a key player in the tumor microenvironment. Focusing on MACC1, this article briefly discusses its biological effects, emphasizes its molecular mechanisms and pathways of action, and describes its use in the treatment and prevention of breast cancer.
format Online
Article
Text
id pubmed-10045309
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100453092023-03-29 MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer Lv, Mengmeng Jiao, Yunjuan Yang, Bowen Ye, Mengchen Di, Wenyu Su, Wei Zhong, Jiateng Biology (Basel) Review SIMPLE SUMMARY: Despite significant advances in treatment, breast cancer continues to be prevalent around the world. Metastasis associated in colon cancer 1 (MACC1) has been shown to be involved in the progression of more than 20 different types of cancer, including breast cancer, and performs specific functions in different cancers. MACC1’s biological role, molecular mechanism, and pathway are important for understanding cancer progression. MACC1 is highly expressed in breast cancer and has been linked to metastasis, staging, and a poor prognosis. This review article attempts to elucidate the prognostic value of MACC1 expression in breast cancer, its role in immune and anti-radiation therapy, and the network regulatory mechanisms involved, and discusses the application of MACC1 in the treatment and prevention of breast cancer. It is hoped that the use of MACC1 as a biomarker in breast cancer surveillance and clinical guidance can be promoted. ABSTRACT: Metastasis associated in colon cancer 1 (MACC1) is an oncogene first identified in colon cancer. MACC1 has been identified in more than 20 different types of solid cancers. It is a key prognostic biomarker in clinical practice and is involved in recurrence, metastasis, and survival in many types of human cancers. MACC1 is significantly associated with the primary tumor, lymph node metastasis, distant metastasis classification, and clinical staging in patients with breast cancer (BC), and MACC1 overexpression is associated with reduced recurrence-free survival (RFS) and worse overall survival (OS) in patients. In addition, MACC1 is involved in BC progression in multiple ways. MACC1 promotes the immune escape of BC cells by affecting the infiltration of immune cells in the tumor microenvironment. Since the FGD5AS1/miR-497/MACC1 axis inhibits the apoptotic pathway in radiation-resistant BC tissues and cell lines, the MACC1 gene may play an important role in BC resistance to radiation. Since MACC1 is involved in numerous biological processes inside and outside BC cells, it is a key player in the tumor microenvironment. Focusing on MACC1, this article briefly discusses its biological effects, emphasizes its molecular mechanisms and pathways of action, and describes its use in the treatment and prevention of breast cancer. MDPI 2023-03-16 /pmc/articles/PMC10045309/ /pubmed/36979146 http://dx.doi.org/10.3390/biology12030455 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lv, Mengmeng
Jiao, Yunjuan
Yang, Bowen
Ye, Mengchen
Di, Wenyu
Su, Wei
Zhong, Jiateng
MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer
title MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer
title_full MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer
title_fullStr MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer
title_full_unstemmed MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer
title_short MACC1 as a Potential Target for the Treatment and Prevention of Breast Cancer
title_sort macc1 as a potential target for the treatment and prevention of breast cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045309/
https://www.ncbi.nlm.nih.gov/pubmed/36979146
http://dx.doi.org/10.3390/biology12030455
work_keys_str_mv AT lvmengmeng macc1asapotentialtargetforthetreatmentandpreventionofbreastcancer
AT jiaoyunjuan macc1asapotentialtargetforthetreatmentandpreventionofbreastcancer
AT yangbowen macc1asapotentialtargetforthetreatmentandpreventionofbreastcancer
AT yemengchen macc1asapotentialtargetforthetreatmentandpreventionofbreastcancer
AT diwenyu macc1asapotentialtargetforthetreatmentandpreventionofbreastcancer
AT suwei macc1asapotentialtargetforthetreatmentandpreventionofbreastcancer
AT zhongjiateng macc1asapotentialtargetforthetreatmentandpreventionofbreastcancer